SPB07479

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Ahmed, Shakil: 1 article (12/2014)
2.	Gupta, Priyanka: 1 article (12/2014)
3.	Khan, Saman: 1 article (12/2014)
4.	Kumar, Vikash: 1 article (12/2014)
5.	Mishra, Durga Prasad: 1 article (12/2014)
6.	Rastogi, Namrata: 1 article (12/2014)
7.	Siddiqi, Mohammad Imran: 1 article (12/2014)

1.	Pancreatic Neoplasms (Pancreatic Cancer) 12/01/2014 - "Validation studies using normal and human cancer cell lines, indicated that SPB07479 significantly inhibited proliferation of cervical cancer cells as a single agent and chemosensitized glioma and pancreatic cancer cell lines to standard chemotherapy while sparing normal cells. "
2.	Neoplasms (Cancer) 12/01/2014 - "Validation studies using normal and human cancer cell lines, indicated that SPB07479 significantly inhibited proliferation of cervical cancer cells as a single agent and chemosensitized glioma and pancreatic cancer cell lines to standard chemotherapy while sparing normal cells. "
3.	Glioma (Gliomas) 12/01/2014 - "Validation studies using normal and human cancer cell lines, indicated that SPB07479 significantly inhibited proliferation of cervical cancer cells as a single agent and chemosensitized glioma and pancreatic cancer cell lines to standard chemotherapy while sparing normal cells. "
4.	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/01/2014 - "Validation studies using normal and human cancer cell lines, indicated that SPB07479 significantly inhibited proliferation of cervical cancer cells as a single agent and chemosensitized glioma and pancreatic cancer cell lines to standard chemotherapy while sparing normal cells. "

1.	Drug Therapy (Chemotherapy)